Denmark began nationwide RSV vaccination for pregnant people on 1 October 2025, protecting babies through maternal antibodies for about six months. High-risk newborns of unvaccinated mothers received monoclonal antibodies, and researchers found unexpectedly few RSV hospitalizations.